| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |